Lilly GMP Strategy: Avoid Consent Degree With Open Communication At FDA

Lilly's ongoing, "open" communication with FDA over good manufacturing practices should help avoid a consent decree, CFO Charles Golden said during the Bear Stearns healthcare conference in New York Sept. 19